Search Results

Daniel J Crawford, MD

Daniel J Crawford, MD, Acting Assistant Professor

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children per Standard of Care / (POPS): NICHD-2019-POP02-STUDY00002420

Prospective, multicenter study of understudied drugs. Participants will receive drugs of interest administered per standard of care. Primary:...

Phase 1b/2, randomized, double-blind, placebo-controlled, multi-center study of STMC-103H in neonates and infants at high-risk for developing allergic disease-STUDY00003212

Primary indication is to see is STMC-103H, prevents allergic disease in at-risk neonates. The primary objective of this study is to assess the...

Anna Rose Forsyth, DDS

Anna Rose Forsyth, DDS

Florence Omoro Smith, ARNP

Florence Omoro Smith, ARNP

Amber Michelle Rogers Bock, ARNP

Amber Michelle Rogers Bock, ARNP specializing in Hospital Medicine, Urgent Care

Resiliency in Families Affected by Congenital Heart Disease-STUDY00002036

To learn more about this study, please email the study team member listed below.

A Post-Authorization Safety Study (PASS) to Assess Long-term Safety in Patients with Pompe Disease Treated with Avalglucosidase alfa in the Real-World Setting: the SAVANT (Safety assessment of AValglucosidase Alfa as a Novel Treatment) study-STUDY00005276

To collect long term safety data and evaluate the important identified risk of infusion associated reactions (IARs) including hypersensitivity and...

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS 181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects-STUDY00002095

This is a multi-center, randomized, double-blind, placebo-controlled Phase III study to investigate the efficacy and safety of DAS181 for the...

Anne F Reeves, DDS, MPH

Anne F Reeves, DDS, MPH specializing in Dentistry